ArticleInternational journal of molecular sciences2023
Evaluation of Chelator-to-Antibody Ratio on Development of
Shih-Chuan Tsai, Shiou-Shiow Farn, Wei-Lin Lo, Fang-Yu Ou Yang, Yong-Ching Kang, Liang-Cheng Chen, Kuo-Ting Chen, Jiunn-Wang Liao, Jui-Yin Kung, Jenn-Tzong Chen and 1 more
Open access · goldAbstract read
In one paragraphArticle in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors at 4 institutions in 1 country.
Shih-Chuan TsaiDepartment of Nuclear Medicine, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
Shiou-Shiow FarnNational Atomic Research Institute, Taoyuan 325207, Taiwan.
Wei-Lin LoNational Atomic Research Institute, Taoyuan 325207, Taiwan.
Fang-Yu Ou YangNational Atomic Research Institute, Taoyuan 325207, Taiwan.
Yong-Ching KangDepartment of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung 406053, Taiwan.
Liang-Cheng ChenNational Atomic Research Institute, Taoyuan 325207, Taiwan.
Jiunn-Wang LiaoGraduate Institute of Veterinary Pathobiology, National Chung-Hsing University, Taichung 402202, Taiwan.ORCID 0000-0001-7374-1203 Jui-Yin KungDepartment of Nuclear Medicine, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
Jenn-Tzong ChenNational Atomic Research Institute, Taoyuan 325207, Taiwan.
Feng-Yun J HuangDepartment of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung 406053, Taiwan.ORCID 0000-0002-7664-0368 Central Taiwan University of Science and Technology · TWTaichung Veterans General Hospital · TWNational Chung Hsing University · TWNational Dong Hwa University · TW
Funding
Central Taiwan University of Science and Technology CTU110-P-101Ministry of Science and Technology and Atomic Energy Council in Taiwan for the mutual fund grant MOST 111-2623-E-166-001-NUTaichung Veterans General Hospital/Central Taiwan University of Science and Technology Joint Research Program TCVGH-CTUST-1117703
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Chelating AgentsNeoplasmsAnimalsAntibodies, MonoclonalB7-H1 AntigenCell Line, TumorDeferoxamineHumansMicePositron-Emission TomographyRadioisotopesTissue DistributionZirconiumAntibodies, MonoclonalB7-H1 AntigenChelating AgentsDeferoxamineRadioisotopesZirconium89Zrchelator-to-antibody ratioDFOiPETPD-L1/PD-1
Identifiers
PMID38138961
PMCPMC10743313
OpenAlexW4389346589
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390